Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



AMSBIO has added an important new product to its immunotherapy range - a PD-L2 / TCR activator - CHO Recombinant Cell Line.

AMSBIO has added an important new product to its immunotherapy range - a PD-L2 / TCR activator - CHO Recombinant Cell Line. PD-L2 is one of the key players in immune checkpoint therapy, which is the focus of the 2018 Nobel Prize for Physiology & Medicine . This work pioneered by Professor James P Allison from the USA and Professor Tasuku Honjo from Japan, has led to treatments for cancers, such as melanoma, lung cancer and others based upon immune checkpoint therapy

Read the rest of entry »

Synpromics Unveils Next Generation Liver Selective and Tunable Promoter Platform

Synpromics is today unveiling its novel drug-regulatable promoter platform at the European Society of Cell and Gene Therapy (ESGCT) congress in Lausanne, Switzerland. The company is showcasing data generated from its innovative liver inducible and repressible synthetic promoter systems that are tightly controlled by FDA-approved small molecule drugs.

Read the rest of entry »

OBN Awards 2018 – Winners Recognised at Industry Leading Event

The OBN Annual Awards celebrates the achievements of the UK life sciences industry.

Read the rest of entry »

Tissue Solutions Ltd expands service offering with HistologiX Ltd. acquisition

HistologiX Ltd, a leading GLP/GCP compliant IHC and Histology lab, has been acquired by The Intelligent Tissue Group Ltd, joining Tissue Solutions Ltd, world leaders in human tissue provision, to provide a comprehensive integrated range of tissue related CRO services.

Read the rest of entry »

ScreenIn3D, a partner of AMSBIO, reports on the accolades it has received following the recent launch of its novel microfluidic cancer screening service.

ScreenIn3D, a partner of AMSBIO, reports on the accolades it has received following the recent launch of its novel microfluidic cancer screening service. Combining the latest advances in microfluidics and 3D culture - the service uses an optimised screening platform targeted at improving anticancer drug treatment and accelerating development of new personalised medicine solutions.

Read the rest of entry »

SynbiCITE launches new five-year strategy

SynbiCITE, the UK’s national centre for commercialisation of synthetic biology, is pleased to announce the launch of a new five-year strategy underpinned by a new £5M grant from UKRI and other sources. The new strategy will see the launch of SynbiCITE 2.0, which aims to expand and develop SynbiCITE’s reach within the UK’s synthetic biology innovation and academic ecosystem, and create a single highly interconnected UK innovation cluster.

Read the rest of entry »

Innovate UK Awards OBN Member Medherant a Medicines Manufacturing Grant

Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has been awarded a Medicines Manufacturing Grant by Innovate UK. The grant will enable the Company to buy equipment and move forward with its plans to extend its pilot scale manufacture of patches formulated with its unique TEPI Patch® technology to GMP manufacture for clinical trials.

Read the rest of entry »

Isansys Lifecare named as one of the top companies in the UK which could help save the NHS millions

Isansys Lifecare's Patient Status Engine wireless patient monitoiring platform could help deliver millions of pounds worth of savings to the NHS.

Read the rest of entry »

Thermo Fisher Scientific brought Science World successfully back to Manchester

Science World, the Fisher Scientific Laboratory Experience, made its successful return to Emirates Old Trafford – Lancashire County Cricket Club, Manchester on 27 September. The event, hosted by Thermo Fisher Scientific, showcased the latest in laboratory innovations available through Fisher Scientific.

Read the rest of entry »

Scotland’s Life Sciences Start-Ups to benefit from BioCity’s specialist support

Life sciences incubator, BioCity, has won a contract tendered by Scottish Enterprise to provide specialist support and advice to all its life science start-ups in Scotland.The minimum three-year contract will see BioCity provide specialist coaches and consultants to help and support the next generation of life science start-ups in Scotland to achieve their potential.

Read the rest of entry »

Pages: Previous1234567...42NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.